Used as a key intermediate in the synthesis of liquid crystal materials for display technologies. Its structure supports the formation of stable mesophases, making it valuable in advanced LCD applications. Also employed in pharmaceutical research as a building block for bioactive molecules, particularly in development of anti-inflammatory and antiviral agents. The electron-withdrawing trifluoromethyl group enhances metabolic stability in drug design, improving compound performance in medicinal chemistry.